Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Will there be another Wave

Remember this

CUPERTINO, Calif. – October 5, 2009 – Alliacense announced today a wave of new MMP™ Portfolio licensees less than three weeks after the USPTO announced it's decision to affirm the validity of US’336, the most widely recognized patent in the MMP Portfolio.

Nearly 4 years later....are we positioned for a "tidal wave"

Share
New Message
Please login to post a reply